Literature DB >> 9405160

Conformational flexibility and polymerization of vesicular stomatitis virus matrix protein.

Y Gaudin1, J Sturgis, M Doumith, A Barge, B Robert, R W Ruigrok.   

Abstract

The matrix protein of vesicular stomatitis virus (VSV) plays a pivotal role in viral assembly. We previously demonstrated the ability of M protein to self-associate at low salt concentrations. Now, we show the ability of M protein to polymerize in the presence of ZnCl2 in a nucleation-dependent manner. Analysis of kinetics revealed that the nuclei are probably made of three or four molecules of M. These results are consistent with the idea that in vitro self association of M protein is not due to amorphous aggregation but rather reflects an intrinsic ability of M to polymerize. Using attenuated total reflectance Fourier transform infrared spectroscopy, we showed that M polymerization is associated with an increase in the beta-sheet content of the protein. We propose a model explaining both the apparent M protein solubility in infected cells and how M polymerization could promote viral assembly. Data available for other negative strand viruses suggest that M polymerization may be the general basis of viral assembly. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405160     DOI: 10.1006/jmbi.1997.1439

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Membrane association induces a conformational change in the Ebola virus matrix protein.

Authors:  S Scianimanico; G Schoehn; J Timmins; R H Ruigrok; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Crystal structure of the matrix protein VP40 from Ebola virus.

Authors:  A Dessen; V Volchkov; O Dolnik; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

3.  A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Masayuki Shirakura; Tsuyoshi Tokusumi; Takahiro Hirata; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  Characterization of the Interaction between the Matrix Protein of Vesicular Stomatitis Virus and the Immunoproteasome Subunit LMP2.

Authors:  Frauke Beilstein; Linda Obiang; Hélène Raux; Yves Gaudin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

5.  Expression, purification and crystallization of a lyssavirus matrix (M) protein.

Authors:  René Assenberg; Olivier Delmas; Stephen C Graham; Anil Verma; Nick Berrow; David I Stuart; Raymond J Owens; Hervé Bourhy; Jonathan M Grimes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

Review 6.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

7.  The matrix protein of vesicular stomatitis virus binds dynamin for efficient viral assembly.

Authors:  Hélène Raux; Linda Obiang; Nicolas Richard; Francis Harper; Danielle Blondel; Yves Gaudin
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

8.  Cryo-EM model of the bullet-shaped vesicular stomatitis virus.

Authors:  Peng Ge; Jun Tsao; Stan Schein; Todd J Green; Ming Luo; Z Hong Zhou
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

9.  Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties.

Authors:  Piotr Neumann; Diana Lieber; Sylke Meyer; Philipp Dautel; Andreas Kerth; Ina Kraus; Wolfgang Garten; Milton T Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus.

Authors:  Jun-Young Seo; William J Britt
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.